RELATING TO THE UNIFORM CONTROLLED SUBSTANCE ACT.

HB1133

HOUSE OF REPRESENTATIVES

H.B. NO.

1133

THIRTY-THIRD LEGISLATURE, 2025

STATE OF HAWAII

A BILL FOR AN ACT

RELATING
TO THE UNIFORM CONTROLLED SUBSTANCE ACT
.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

����
SECTION 1.
�
Section 329-14, Hawaii Revised Statutes, is
amended as follows:

����
1.
�
By amending subsection (b) to read:

����
"(b)

�
Any of the following opiates, including
their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers,
unless specifically excepted, whenever the existence of these isomers, esters,
ethers, and salts is possible within the specific chemical designation:

����
(1)
�
Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);

����
(2)
�
Acetylmethadol;

����
(3)
�
Acetyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and
geometric isomers, salts, and salts of isomers;

����
(4)
�
Acryl fentanyl
[N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name:
�
acryloylfentanyl);

����
(5)
�
AH-7921
(3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);

����
(6)
�
Allylprodine;

����
(7)
�
Alphacetylmethadol (except
levo-alphacetylmethadol, levomethadyl acetate, or LAAM);

����
(8)
�
Alphameprodine;

����
(9)
�
Alphamethadol;

���
(10)
�
Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

��
[
(10)
]

(11)

�
Alpha-methylfentanyl
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide;
1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);

��
[
(11)
]

(12)

�
Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

��
[
(12)
]

(13)

�
Benzethidine;

��
[
(13)
]

(14)
�
Benzylfentanyl
(N-[1-benzyl-4-piperidyl]-N-phenylpropanamide), its optical isomers, salts, and
salts of isomers;

��
[
(14)
]

(15)

�
Betacetylmethadol;

��
[
(15)
]

(16)

�
Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);

��
[
(16)
]

(17)
�
Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

��
[
(17)
]

(18)

�
Beta-hydroxythiofentanyl
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);

��
[
(18)
]

(19)

�
Betameprodine;

��
[
(19)
]

(20)
�
Betamethadol;

��
[
(20)
]

(21)
�
Beta-methyl fentanyl
(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name:
�
[beta]-methyl fentanyl);

��
[
(21)
]

(22)

�
Beta'-phenyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names:
�
[beta]'-phenyl fentanyl; 3-phenylpropanoyl
fentanyl);

��
[
(22)
]

(23)

�
Betaprodine;

���
(24)
�
Brorphine
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one;

��
[
(23)
]

(25)
�
Butyryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);

��
[
(24)
]

(26)
�
Clonitazene;

��
[
(25)
]

(27)
�
Cyclopropyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);

��
[
(26)
]

(28)

�
Dextromoramide;

��
[
(27)
]

(29)

�
Diampromide;

��
[
(28)
]

(30)
�
Diethylthiambutene;

��
[
(29)
]

(31)
�
Difenoxin;

��
[
(30)]

(32)

�
Dimenoxadol;

��
[
(31)
]

(33)
�
Dimepheptanol;

���
(34)
�
2′,5′-dimethoxyfentanyl
(N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);

��
[
(32)
]

(35)

�
Dimethylthiambutene;

��
[
(33)
]

(36)

�
Dioxaphetyl butyrate;

��
[
(34)
]

(37)
�
Dipipanone;

��
[
(35)
]

(38)
�
Ethylmethylthiambutene;

���
(39)
�
Etodesnitazene
(2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) (Other
name:
�
etazene);

��
[
(36)
]

(40)
�
Etonitazene;

��
[
(37)
]

(41)

�
Etoxeridine;

��
[
(38)
]

(42)

�
Fentanyl carbamate (ethyl
(1-phenethylpiperidin-4-yl)(phenyl)carbamate);

��
[
(39)
]

(43)
�
4-fluoroisobutyryl fentanyl
[N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other name:
�
para-fluoroisobutyryl fentanyl);

��
[
(40)
]

(44)
�
2'-fluoro ortho-fluorofentanyl
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other
name: 2'-fluoro 2-fluorofentanyl);

��
[
(41)
]

(45)
�
Furanyl fentanyl
(N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide);

���
(46)
�
3-furanyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);

��
[
(42)
]

(47)

�
Furethidine;

��
[
(43)
]

(48)

�
Hydroxypethidine;

���
(49)
�
Isovaleryl fentanyl
(3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

��
[
(44)
]

(50)

�
Ketobemidone;

��
[
(45)
]

(51)

�
Levomoramide;

��
[(
46)
]

(52)

�
Levophenacylmorphan;

���
(53)
�
Meta-fluorofentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

���
(54)
�
Meta-fluoroisobutyryl fentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

��
[
(47)
]

(55)
�
Methoxyacetyl fentanyl
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);

���
(56)
�
2-Methyl AP-237
(1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);

���
(57)
�
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);

��
[
(48)
]

(58)
�
4'-methyl acetyl fentanyl
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);

��
[
(49)
]

(59)

�
3-methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);

��
[
(50)
]

(60)

�
3-methylthiofentanyl
(N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);

��
[
(51)
]

(61)
�
Morpheridine;

��
[
(52)
]

(62)

�
MPPP
(1-methyl-4-phenyl-4-propionoxypiperidine);

���
(63)
�
N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine
(other name:
�
protonitazene);

���
(64)
�
N-pyrrolidino etonitazene
(2-(4-ethoxybenzyl)-5-nitro-1(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)
(other name:
�
etonitazepyne);

��
[
(53)
]

(65)
Noracymethadol;

��
[
(54)
]

(66)

�
Norlevorphanol;

��
[
(55)
]

(67)

�
Normethadone;

��
[
(56)
]

(68)

�
Norpipanone;

��
[
(57)
]

(69)
�
Ocfentanil
[N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];

��
[
(58)
]

(70)

�
Ortho-fluoroacryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);

��
[
(59)
]

(71)

�
Ortho-fluorobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name:
�
2-fluorobutyryl fentanyl);

���
(72)
�
Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

��
[
(60)
]

(73)

�
Ortho-fluorofentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name:
�
2-fluorofentanyl);

��
[
(61)
]

(74)
�
Ortho-fluoroisobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

��
[
(62)
]

(75)
�
Ortho-methyl acetylfentanyl
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name:
�
2-methyl acetylfentanyl);

��
[
(63)
]

(76)
�
Ortho-methyl methoxyacetyl fentanyl
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other
name:
�
2-methyl methoxyacetyl fentanyl);

��
[
(64)
]

(77)

�
Para-fluorobutyryl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);

��
[
(65)
]

(78)

�
Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide;

��
[
(66)
]

(79)
�
Para-fluoro furanyl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

���
(80)
�
Para-methoxyfuranyl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

���
(81)
�
Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

��
[
(67)
]

(82)
�
Para-methylfentanyl
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other name:
�
4-methylfentanyl);

��
[
(68)
]

(83)

�
PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);

��
[
(69)
]

(84)

�
Phenadoxone;

��
[
(70)
]

(85)

�
Phenampromide;

��
[
(71)
]

(86)

�
Phenomorphan;

��
[
(72)
]

(87)

�
Phenoperidine;

��
[
(73)
]

(88)
�
Phenyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name:
�
benzoyl fentanyl);

��
[
(74)
]

(89)

�
Piritramide;

��
[
(75)
]

(90)

�
Proheptazine;

��
[
(76)
]

(91)

�
Properidine;

��
[
(77)
]

(92)

�
Propiram;

��
[
(78)
]

(93)

�
Racemoramide;

��
[
(79)
]

(94)

�
Thenylfentanyl
(N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers,
salts, and salts of isomers;

��
[
(80)
]

(95)

�
Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);

��
[
(81)
]

(96)
�
Thiofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other names:
�
2-thiofuranyl fentanyl; thiophene fentanyl);

��
[
(82)
]

(97)

�
Tilidine;

��
[
(83)
]

(98)

�
Trimeperidine; and

��
[
(84)
]

(99)

�
U-47700
(3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide."

����
2.
�
By amending subsection (d) to read:

����
"(d)
�
Hallucinogenic substances.
�
Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation that
contains any quantity of the following hallucinogenic substances, including their
salts, isomers, and salts of isomers, whenever the existence of these salts,
isomers,
�
and salts of isomers is possible
within the specific chemical designation:

����
(1)
�
Alpha-ethyltryptamine (AET);

����
(2)
�
2,5-dimethoxy-4-ethylamphetamine
(DOET);

����
(3)
�
2,5-dimethoxyamphetamine (2,5-DMA);

����
(4)
�
3,4-methylenedioxy amphetamine;

����
(5)
�
3,4-methylenedioxymethamphetamine
(MDMA);

����
(6)
�
N-hydroxy-3,4-methylenedioxyamphetamine
(N-hydroxy-MDA);

����
(7)
�
3,4-methylenedioxy-N-ethylamphetamine
(MDE);

����
(8)
�
5-methoxy-3,4-methylenedioxy-amphetamine;

����
(9)
�
4-bromo-2,5-dimethoxy-amphetamine
(4-bromo-2,5-DMA);

���
(10)
�
4-Bromo-2,5-dimethoxyphenethylamine
(Nexus);

���
(11)
�
3,4,5-trimethoxy amphetamine;

���
(12)
�
Bufotenine;

���
(13)
�
4-methoxyamphetamine (PMA);

���
(14)
�
Diethyltryptamine;

���
(15)
�
Dimethyltryptamine;

���
(16)
�
4-methyl-2,5-dimethoxy-amphetamine;

���
(17)
�
Gamma hydroxybutyrate (GHB) (some other
names include gamma hydroxybutyric acid; 4-hydroxybutyrate; 4-hydroxybutanoic
acid; sodium oxybate; sodium oxybutyrate);

���
(18)
�
Ibogaine;

���
(19)
�
Lysergic acid diethylamide;

���
(20)
�
Marijuana;

���
(21)
�
Parahexyl;

���
(22)
�
Mescaline;

���
(23)
�
Peyote;

���
(24)
�
N-ethyl-3-piperidyl benzilate;

���
(25)
�
N-methyl-3-piperidyl benzilate;

���
(26)
�
Psilocybin;

���
(27)
�
Psilocyn;

���
(28)
�
1-[1-(2-Thienyl) cyclohexyl]
Pyrrolidine (TCPy);

���
(29)
�
Ethylamine analog of phencyclidine
(PCE);

���
(30)
�
Pyrrolidine analog of phencyclidine
(PCPy, PHP);

���
(31)
�
Thiophene analog of phencyclidine
(TPCP; TCP);

���
(32)
�
Gamma-butyrolactone, including
butyrolactone; butyrolactone gamma; 4-butyrolactone; 2(3H)-furanone dihydro;
dihydro-2(3H)furanone; tetrahydro-2-furanone; 1,2-butanolide; 1,4-butanolide;
4-butanolide; gamma-hydroxybutyric acid lactone; 3-hydroxybutyric acid lactone
and 4-hydroxybutanoic acid lactone with Chemical Abstract Service number
96-48-0 when any such substance is intended for human ingestion;

���
(33)
�
1,4 butanediol, including butanediol;
butane-1,4-diol; 1,4- butylenes glycol; butylene glycol; 1,4-dihydroxybutane;
1,4- tetramethylene glycol; tetramethylene glycol; tetramethylene 1,4- diol
with Chemical Abstract Service number 110-63-4 when any such substance is
intended for human ingestion;

���
(34)
�
2,5-dimethoxy-4-(n)-propylthiophenethylamine
(2C-T-7), its optical isomers, salts, and salts of isomers;

���
(35)
�
N-benzylpiperazine (BZP;
1-benzylpiperazine), its optical isomers, salts, and salts of isomers;

���
(36)
�
1-(3-trifluoromethylphenyl)piperazine
(TFMPP), its optical isomers, salts, and salts of isomers;

���
(37)
�
Alpha-methyltryptamine (AMT);

���
(38)
�
5-methoxy-N,N-diisopropyltryptamine
(5-MeO-DIPT);

���
(39)
�
Salvia divinorum;

���
(40)
�
Salvinorin A;

���
(41)
�
Divinorin A;

���
(42)
�
5-Methoxy-N,N-Dimethyltryptamine
(5-MeO-DIPT)

(some trade or other names:
�
5-methoxy-3-[2-(dimethylamino)ethyl]indole;
5-MeO-DMT);

���
(43)
�
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
(2C-E);

���
(44)
�
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
(2C-D);

���
(45)
�
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
(2C-C);

���
(46)
�
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine
(2C-I);

���
(47)
�
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-2);

���
(48)
�
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-4);

���
(49)
�
2-(2,5-Dimethoxyphenyl)ethanamine
(2C-H);

���
(50)
�
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine
(2C-N);

���
(51)
�
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine
(2C-P);

���
(52)
�
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
25I-NBOMe; 2C-I-NBOMe;
25I; Cimbi-5);

���
(53)
�
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
25C-NBOMe; 2C-C-NBOMe;
25C; Cimbi-82);

���
(54)
�
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
25B-NBOMe; 2C-B-NBOMe;
25B; Cimbi-36);

���
(55)
�
N-ethylhexedrone, its optical,
positional, and geometric isomers, salts, and salts of isomers (Other
names:
�
[alpha]-ethylaminohexanophenone;
2-(ethylamino)-1-phenylhexan-1-one);

���
(56)
�
Alpha-pyrrolidinohexanophenone, its
optical, positional, and geometric isomers, salts, and salts of isomers (Other
names:
�
[alpha]-PHP;
[alpha]-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one);

���
(57)
�
4-methyl-alpha-ethylaminopentiophenone,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
4-MEAP;
2-(ethylamino)-1-(4-methylphenyl)pentan-1-one);

���
(58)
�
4'-methyl-alpha-pyrrolidinohexiophenone,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone;
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one);

���
(59)
�
Alpha-pyrrolidinoheptaphenone, its
optical, positional, and geometric isomers, salts, and salts of isomers (Other names:
�
PV8;
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one);

���
(60)
�
4'-chloro-alpha-pyrrolidinovalerophenone,
its optical, positional, and geometric isomers, salts, and salts of isomers
(Other names:
�
4-chloro-[alpha]-PVP; 4'-chloro-[alpha]-pyrrolidinopentiophenone;
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one); [
and
]

���
(61)
�
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
(methoxetamine, MXE)[
.
]
;

���
(62)
�
Eutylone
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one)(other name:
�
bk-EBDB); and

���
(63)
�
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol),
including its isomers, esters, ethers, salts, and salts of isomers, esters and
ethers, whenever the existence of such isomers, esters, ethers and salts is
possible within the specific chemical designation.
"

����
3.
�
By amending subsection (f) to read:

����
"(f)
�
Stimulants.
�

Unless specifically excepted or unless listed in another schedule, any
material, compound, mixture, or preparation that contains any quantity of the
following substances having a stimulant effect on the central nervous system,
including its salts, isomers, and salts of isomers:

����
(1)
�
Amineptine;

���
[
(1)
]

(2)

�
Aminorex;

���
[
(2)
]

(3)

�
Cathinone;

���
[
(3)
]

(4)
�
4,4'-dimethylaminorex (common name: 4,4'-DMAR);

���
[
(4)
]

(5)

�
Fenethylline;

����
(6)
�
Mesocarb (chemical name:
�
N-phenyl-N'

-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate);

���
[
(5)
]

(7)
�
Methcathinone;

����
(8)
�
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine);

���
[
(6)
]

(9)

�
4-methylaminorex;

���
[
(7)
]

(10)

�
N-ethylamphetamine;

���
[
(8)
]

(11)

�
N,N-dimethylamphetamine;

���
[
(9)
]

(12)

�
Substituted cathinones, any compound, except
bupropion or compounds listed under a different schedule, structurally derived
from 2-aminopropan-1-one by substitution at the 1-position with either phenyl,
naphthyl, or thiophene ring systems, whether or not the compound is further
modified in any of the following ways:

���������
(A)
�
By substitution in the ring system to
any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring system by one or
more other univalent substituents;

���������
(B)
�
By substitution at the 3-position with
an acyclic alkyl substituent; or

���������
(C)
�
By substitution at the 2-amino nitrogen
atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by inclusion of
the 2-amino nitrogen atom in a cyclic structure.

���������
Some
other trade names: Mephedrone (2-methylamino-1-p-tolylpropan-1-one), also known
as 4-methylmethcathinone (4-MMC), methylephedrone or MMCAT;
Methylenedioxypyrovalerone (MDPV, MDPK); methylone or
3,4-methylenedioxymethcathinone; and 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)propan-1-one,
monohydrochloride, also known as Ethylone, bk-MDEA hydrochloride, MDEC;
3,4-Methylenedioxy-N-ethylcathinone; bk-Methylenedioxyethylamphetamine,
4-methyl-N-ethylcathinone (4-MEC); 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP);
alpha-pyrrolidinopentiophenone ([alpha]-PVP);
1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB e);
2-(methylamino)-1-phenylpentan-1-one (pentedrone);
1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP);
4-fluoro-N-methylcathinone (4-FMC, flephedrone); 3-fluoro-N-methylcathinone
(3-FMC); 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone);
alpha-pyrrolidinobutiophenone ([alpha]-PBP) and their optical, positional, and
geometric isomers, salts and salts of isomers, whenever the existence of such
salts, isomers, and salts of isomers is possible; and

��
[
(10)
]

(13)

�
1-(4-methoxyphenyl)-N-methylpropan-2-amine
(Other names:
�
para-methoxymethamphetamine; PMMA)."

����
SECTION
2.
�
Section 329-20, Hawaii Revised
Statutes, is amended to read as follows:

����
"
�329-20

�
Schedule IV.

�
(a)
�
The
controlled substances listed in this section are included in schedule IV.

����
(b)

�
Depressants.
�
Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation that
contains any quantity of the following substances, including its salts,
isomers, esters, ethers, and salts of isomers, whenever the existence of these
isomers, esters, ethers, and salts is possible within the specific chemical
designation, that has a degree of danger or probable danger associated with a
depressant effect on the central nervous system:

����
(1)
�
Alprazolam;

����
(2)
�
Barbital;

����
(3)
�
Brexanolone;

����
(4)
�
Bromazepam;

����
(5)
�
Butorphanol;

����
(6)
�
Camazepam;

����
(7)
�
Carisoprodol;

����
(8)
�
Chloral betaine;

����
(9)
�
Chloral hydrate;

���
(10)
�
Chlordiazepoxide;

���
(11)
�
Clobazam;

���
(12)
�
Clonazepam;

���
(13)
�
Clorazepate;

���
(14)
�
Clotiazepam;

���
(15)
�
Cloxazolam;

���
(16)
�
Daridorexant;

���
(17)
�
Delorazepam;

���
(18)
�
Diazepam;

���
(19)
�
Dichloralphenazone (Midrin);

���
(20)
�
Estazolam;

���
(21)
�
Ethchlorvynol;

���
(22)
�
Ethinamate;

���
(23)
�
Ethyl loflazepate;

���
(24)
�
Fludiazepam;

���
(25)
�
Flunitrazepam;

���
(26)
�
Flurazepam;

���
(27)
�
Fospropofol (Lusedra);

���
(28)
�
Halazepam;

���
(29)
�
Haloxazolam;

���
(30)
�
Ketazolam;

���
(31)
�
Lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide);

���
(32)
�
Loprazolam;

���
(33)
�
Lorazepam;

���
(34)
�
Lormetazepam;

���
(35)
�
Mebutamate;

���
(36)
�
Medazepam;

���
(37)
�
Meprobamate;

���
(38)
�
Methohexital;

���
(39)
�
Methylphenobarbital (mephorbarbital);

���
(40)
�
Midazolam;

���
(41)
�
Nimetazepam;

���
(42)
�
Nitrazepam;

���
(43)
�
Nordiazepam;

���
(44)
�
Oxazepam;

���
(45)
�
Oxazolam;

���
(46)
�
Paraldehyde;

���
(47)
�
Petrichloral;

���
(48)
�
Phenobarbital;

���
(49)
�
Pinazepam;

���
(50)
�
Prazepam;

���
(51)
�
Quazepam;

���
(52)
�
Remimazolam;

���
(53)
�
Suvorexant;

���
(54)
�
Temazepam;

���
(55)
�
Tetrazepam;

���
(56)
�
Triazolam;

���
(57)
�
Zaleplon;

���
(58)
�
Zolpidem; [
and
]

���
(59)
�
Zopiclone (Lunesta)[
.
]and

���
(60)
�
Zuranolone.

����
[
(c)
�
Fenfluramine.
�

Any material, compound, mixture, or preparation which contains any
quantity of the following substances, including its salts, isomers, and salts
of isomers, whenever the existence of such salts, isomers, and salts of isomers
is possible:
�
Fenfluramine.

����
(d)
]

(c)

�
Stimulants.
�
Unless listed in another schedule, any
material, compound, mixture, or preparation which contains any quantity of the
following substances having a stimulant effect on the central nervous system,
including its salts, isomers, and salts of such isomers whenever the existence
of such salts, isomers, and salts of isomers is possible within the specific
chemical designation:

����
(1)
�
Cathine ((+)-norpseudoephedrine);

����
(2)
�
Diethylpropion;

����
(3)
�
Fencamfamin;

����
(4)
�
Fenproporex;

����
(5)
�
Lorcaserin;

����
(6)
�
Mazindol;

����
(7)
�
Mefenorex;

����
(8)
�
Modafinil;

����
(9)
�
Pemoline (including organometallic
complexes and chelates thereof);

���
(10)
�
Phentermine;

���
(11)
�
Pipradrol;

���
(12)
�
Serdexmethylphenidate;

���
(13)
�
Sibutramine;

���
(14)
�
Solriamfetol; and

���
(15)
�
SPA
(1-dimethylamino-1,2-diphenylethane, lefetamine).

����
[
(e)
]

(d)

�
Other substances.
�
Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances, including its optical
isomers and its salts, isomers, and salts of isomers:

����
(1)
�
Pentazocine; and

����
(2)
�
Eluxadoline
(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic
acid.

����
[
(f)
]

(e)
�
The department of law
enforcement may except by rule any compound, mixture, or preparation containing
any depressant substance listed in subsection (b) or any stimulant listed in
subsection [
(d)
]
(c)
from the application of all or any part of
this chapter if the compound, mixture, or preparation contains one or more
active medicinal ingredients not having a depressant or stimulant effect on the
central nervous system, and if the admixtures are included therein in
combinations, quantity, proportion, or concentration that vitiate the degree of
danger or probable danger of the substances which have a depressant or
stimulant effect on the central nervous system.

����
[
(g)
]

(f)
�
Narcotic drugs.
�
Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation containing
any of the following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:

����
(1)
�
Not more than one milligram of
difenoxin and not less than twenty-five micrograms of atropine sulfate per
dosage unit;

����
(2)
�
Dextropropoxyphene
(alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane); and

����
(3)
�
2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol,
its salts, optical and geometric isomers and salts of these isomers (including
tramadol)."

����
SECTION
3.
�
Statutory material to be repealed is
bracketed and stricken.
�
New statutory
material is underscored.

����
SECTION
4.
�
This Act shall take effect upon its
approval.

INTRODUCED BY:

_____________________________

BY REQUEST

Report Title:

Uniform Controlled Substances Act

Description:

Updates
chapter 329, HRS, to make it consistent with amendments in the Federal
Controlled Substances Act as required under section 329-11, HRS.

The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.